Document Type

Article

Publication Date

2019

DOI

10.1002/pst.1948

Publication Title

Pharmaceutical Statistics

Volume

18

Issue

5

Pages

568-582

Abstract

In the medical literature, there has been an increased interest in evaluating association between exposure and outcomes using nonrandomized observational studies. However, because assignments to exposure are not random in observational studies, comparisons of outcomes between exposed and nonexposed subjects must account for the effect of confounders. Propensity score methods have been widely used to control for confounding, when estimating exposure effect. Previous studies have shown that conditioning on the propensity score results in biased estimation of conditional odds ratio and hazard ratio. However, research is lacking on the performance of propensity score methods for covariate adjustment when estimating the area under the ROC curve (AUC). In this paper, AUC is proposed as measure of effect when outcomes are continuous. The AUC is interpreted as the probability that a randomly selected nonexposed subject has a better response than a randomly selected exposed subject. A series of simulations has been conducted to examine the performance of propensity score methods when association between exposure and outcomes is quantified by AUC; this includes determining the optimal choice of variables for the propensity score models. Additionally, the propensity score approach is compared with that of the conventional regression approach to adjust for covariates with the AUC. The choice of the best estimator depends on bias, relative bias, and root mean squared error. Finally, an example looking at the relationship of depression/anxiety and pain intensity in people with sickle cell disease is used to illustrate the estimation of the adjusted AUC using the proposed approaches.

Original Publication Citation

Galadima, HI, McClish, DK. Controlling for confounding via propensity score methods can result in biased estimation of the conditional AUC: A simulation study. Pharmaceutical Statistics. 2019; 18: 568– 582. https://doi.org/10.1002/pst.1948

ORCID

0000-0003-1588-3929 (Galadima)

Share

COinS